Results 21 to 30 of about 4,428,370 (205)

Exploratory Profiling of Extracellular Vesicles and Citrullinated Proteins in Plasma of Greenland Shark Somniosus microcephalus [PDF]

open access: yesBiology
The Greenland shark Somniosus microcephalus is the longest-living vertebrate on Earth. With an estimated lifespan of up to at least 272 years, slow metabolism and resistance to high pressure and cold temperature, its unusual physiology remains poorly ...
Sigrun Lange   +5 more
doaj   +2 more sources

Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca2+ dependent allosteric binding site [PDF]

open access: yesNature Communications
Peptidylarginine deiminases (PAD1-4) are calcium dependent enzymes responsible for protein citrullination, a post-translational modification converting arginine residues to citrulline.
Leslie A. Dakin   +25 more
doaj   +2 more sources

Citrullination in tumor immunity and therapy [PDF]

open access: yesThe Journal of Clinical Investigation
Peptidyl arginine deiminases (PADs) catalyze the conversion of arginine residues into peptidyl citrulline, a posttranslational modification known as protein citrullination (or arginine deimination).
Michael R. Pitter, Weiping Zou
doaj   +2 more sources

Citrullination-associated transcriptional states identify a non-canonical invasive program in malignant epithelial cells and correlate with SPP1-CD44 immune microenvironment niches in thyroid cancer [PDF]

open access: yesTranslational Oncology
Background: Citrullination, a post-translational modification catalyzed by protein arginine deiminases (PADIs), has been implicated in malignant progression across multiple cancer types.
Zhisheng Tian   +3 more
doaj   +2 more sources

Photochemical Control of Protein Arginine Deiminase (PAD) Activity [PDF]

open access: yesACS Chemical Biology, 2018
Protein arginine deiminases (PADs) play an important role in the pathogenesis of various diseases, including rheumatoid arthritis, multiple sclerosis, lupus, ulcerative colitis, and breast cancer. Therefore, the development of PAD inhibitors has drawn significant research interest in recent years.
Santanu Mondal   +3 more
openaire   +3 more sources

Development of a Selective Inhibitor of Protein Arginine Deiminase 2 [PDF]

open access: yesJournal of Medicinal Chemistry, 2017
Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. To date, no PAD2-selective inhibitor has been developed. Such a compound will be critical for elucidating the biological roles of this isozyme and may ultimately be useful for treating specific diseases in ...
Aaron Muth   +9 more
openaire   +3 more sources

Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study [PDF]

open access: yes, 2022
Over 10 million people worldwide live with Parkinson's disease (PD) and 4% of affected people are diagnosed before the age of 50. Research on early PD-related pathways is therefore of considerable importance.
Hristova, M.   +11 more
core   +1 more source

The role of the host—Neutrophil biology

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple   +4 more
wiley   +1 more source

Protein arginine deiminase 4: a target for an epigenetic cancer therapy [PDF]

open access: yesCellular and Molecular Life Sciences, 2010
The recent approvals of anticancer therapeutic agents targeting the histone deacetylases and DNA methyltransferases have highlighted the important role that epigenetics plays in human diseases, and suggested that the factors controlling gene expression are novel drug targets. Protein arginine deiminase 4 (PAD4) is one such target because its effects on
Slack, Jessica L.   +2 more
openaire   +3 more sources

Protein Arginine Deiminase 4:  Evidence for a Reverse Protonation Mechanism [PDF]

open access: yesBiochemistry, 2007
The presumed role of an overactive protein arginine deiminase 4 (PAD4) in the pathophysiology of rheumatoid arthritis (RA) suggests that PAD4 inhibitors could be used to treat an underlying cause of RA, potentially offering a mechanism to stop further disease progression. Thus, the development of such inhibitors is of paramount importance.
Knuckley, Bryan   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy